Dexamethasone Intravitreal Implant Is Active at the Molecular Level Eight Weeks after Implantation in Experimental Central Retinal Vein Occlusion

Central retinal vein occlusion (CRVO) is a visually disabling condition resulting from a thrombus in the major outflow vessel of the eye. The inflammatory response in CRVO is effectively treated with a dexamethasone (DEX) intravitreal implant. Uncovering the proteome changes following DEX implant in...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Lasse Jørgensen Cehofski, Anders Kruse, Mads Odgaard Mæng, Benn Falch Sejergaard, Anders Schlosser, Grith Lykke Sorensen, Jakob Grauslund, Bent Honoré, Henrik Vorum
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-09-01
coleção:	Molecules
Assuntos:	retina retinal vein occlusion mass spectrometry proteomics proteome dexamethasone
Acesso em linha:	https://www.mdpi.com/1420-3049/27/17/5687
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!